TrialThe European respiratory journal2015
Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).
Roland Buhl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
151 papers cite itlatest 60 shown
this paperpooled ittrialcites it